Quarterly report pursuant to Section 13 or 15(d)

Subsequent Events

v3.22.1
Subsequent Events
9 Months Ended
Mar. 31, 2022
Subsequent Events [Abstract]  
Subsequent events

9 Subsequent events

 

Registered direct financing

On April 14, 2022, the Company closed on the sale of 16,266 shares of its common stock, par value $0.001 per share, and common warrants to purchase an aggregate of 16,266 shares of common stock (“2022 April Investor Warrants”) in the Company’s registered direct offering (the “April Offering”). Each share of common stock was sold together with a 2022 April Investor Warrant to purchase one share of common stock at a combined effective price of $0.53 per share of common stock and accompanying 2022 April Investor Warrant. The net proceeds from the April Offering were approximately $7,900 after deducting commissions and other offering expenses. The 2022 April Investor Warrants are exercisable at $0.41 per share until their expiry on April 14, 2027. The Company also issued 811 agent warrants that are exercisable at $0.6625 per share commencing October 14, 2022, until their expiry on October 14, 2026.

Warrants and stock options

 

Subsequent to March 31, 2022, a total of 222 common stock warrants exercisable at a weighted average price of $35.35 per share expired and 280 stock options exercisable at a weighted average exercise price of $1.65 expired.

 

The Company has evaluated its subsequent events from March 31, 2022, through the date these condensed consolidated interim financial statements were issued and has determined that there are no subsequent events requiring disclosure in these condensed consolidated interim financial statements other than the items noted above.